ACTA1 and Bloom syndrome: Parallelly, immunohistochemical staining showed increased expressions of Col-I and α-SMA in BLM-treated mice, and intravenous administration of IMRC-EVs but not MRC5-EVs after BLM exposure reduced the expression of Col-I and α-SMA in the lungs (Fig. 1g, h, k, l).